Acetone oxime

CAS127-06-0
EC204-820-1

List details

Basic info

Status Opinion Adopted
Submitter Austria
Regulatory programme
  • Chemical registered under REACH

Classification

Proposed harmonised classification by the dossier submitter
  • Acute Tox. 4, H312
  • Eye Dam. 1, H318
  • Skin Sens. 1B, H317
  • Carc. 1B, H350
  • STOT SE 3, H336
  • STOT RE 2, H373
Hazard classes open for commenting Carcinogenicity Germ cell mutagenicity Acute Toxicity - dermal Specific target organ toxicity – single exposure Specific target organ toxicity – repeated exposure Skin corrosion/irritation Serious eye damage/eye irritation Skin Sensitisation
Proposed specific concentration limits by the dossier submitter Dermal: ATE = 1100 mg/kg bw

Intention timeline

Date of intention 2020-02-03
Expected date of submission 2020-12-23
Submitted for accordance check 2020-12-21
Final submission date 2021-04-08
Start of consultation 2021-07-05
Deadline for commenting 2021-09-03
Date of opinion 2022-03-18
Legal deadline for opinion adoption 2022-10-08

Documents

CLH report
Comments received
RAC opinion
Background document

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

This version
June 24, 2022
  • Background document: https://echa.europa.eu/documents/10162/8aca789c-a691-6f73-b7a5-aab475931e65
  • Comments received: https://echa.europa.eu/documents/10162/12b45815-4a68-43f1-4eba-f09170e00eae
  • RAC opinion: https://echa.europa.eu/documents/10162/c61f4d2e-2cca-c319-94d7-f1b9d6058171
June 6, 2022
  • Comments received: https://echa.europa.eu/documents/10162/ad41429f-7755-f569-6157-7252e93b8d4d
April 26, 2022
  • Date of opinion: 2022-03-18
  • Status: Opinion DevelopmentOpinion Adopted
Oct. 8, 2021
  • Comments received: https://echa.europa.eu/documents/10162/ad41429f-7755-f569-6157-7252e93b8d4d
  • Status: ConsultationOpinion Development
July 7, 2021
  • CLH report: https://echa.europa.eu/documents/10162/2d0014c7-15e5-675f-bbe2-d869aaf00c1b
  • Deadline for commenting: 2021-09-03
  • Final submission date: 2021-04-08
  • Hazard classes open for commenting: Carcinogenicity Germ cell mutagenicity Acute Toxicity - dermal Specific target organ toxicity – single exposure Specific target organ toxicity – repeated exposure Skin corrosion/irritation Serious eye damage/eye irritation Skin Sensitisation
  • Legal deadline for opinion adoption: 2022-10-08
  • Status: SubmittedConsultation
  • Start of consultation: 2021-07-05
March 1, 2021
  • Submitter: Austria
Feb. 17, 2021
  • Submitter: Austria
Jan. 6, 2021
  • Proposed harmonised classification by the dossier submitter: Acute Tox. 4, H312
  • Proposed harmonised classification by the dossier submitter: Eye Dam. 1, H318
  • Proposed harmonised classification by the dossier submitter: STOT RE 2, H373
  • Proposed harmonised classification by the dossier submitter: STOT SE 3, H336
  • Proposed specific concentration limits by the dossier submitter: Dermal: ATE = 1100 mg/kg bw
  • Status: IntentionSubmitted
  • Submitted for accordance check: 2020-12-21
Add the related substance to your watchlist to monitor this regulatory record.